Print Page     Close Window     

SEC Filings

SC 13G
ARK INVESTMENT MANAGEMENT LLC filed this Form SC 13G on 02/14/2019
Entire Document



CUSIP No. 81750R102 13G Page 3 of 5 Pages 


Item 1(a) Name of issuer:            


Seres Therapeutics, Inc.


Item 1(b) Address of issuer's principal executive offices:            


200 Sidney Street

Cambridge, MA 02139


Item 2(a) Name of person filing:            


ARK Investment Management LLC


Item 2(b) Address or principal business office or, if none, residence:


ARK Investment Management LLC

3 East 28th Street, 7th Floor

New York, NY 10016


Item 2(c) Citizenship:         


Delaware, United States 


Item 2(d) Title of class of securities:             


Common Stock


Item 2(e) CUSIP No.:




Item 3. If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:


(a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);


(b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);


(c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);


(d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);


(e) x An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);


(f) ¨ An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);


(g) ¨ A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);


(h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);


© Seres Therapeutics. All Rights Reserved.